That is not really how it works. You either co-develop or you take a fee. But you dont receive a thing until they start selling the chip.
The company wasnt jeopardised by engaging in a chip co-development, but by pursing 2 parallel strategies without the necessary resources. Rather than picking one Miller chose 2.
Once RealTek came on board, the only strategy NUH needed to focus on was developing the platform , instead they continued being a manufacturer and selling through retail. I can understand why Miller pursed the retail strategy , there was an assumption that NUH could simply continue where it left off in the consumer space to the OTC space. But we are back to poor management and strategy by Miller and co, what was the point of Realtek if the focus was not the platform? Small companies need to focus on one thing,
The company doesnt have to be cash positive to invest money in chip co-development, if that was the case, silcon valley would not exist.
There is a deal in place, it was announced in July 2022 when RealTek came on board. They are not going to disclose the contractual terms to the market, if there was no deal, on what basis did they invest $4-5mln in chip co-development?
NUH needs to focus on the platform and forget the other stuff.
- Forums
- ASX - By Stock
- NUH
- Ann: March 2024 Quarterly Appendix 4C
Ann: March 2024 Quarterly Appendix 4C, page-75
-
-
- There are more pages in this discussion • 192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUH (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NUH (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online